What is it about?
Landmark study that as the first demonstrated that FDG uptake on a PET scan predicts survival of neuroendocrine tumor patients. This can be used for selecting a proper treatment strategy.
Featured Image
Why is it important?
This is the landmark paper that in a prospective design demonstrated that FDG-PET better predicts survival in neuroendocrine tumor patients than current classifications, e.g. Ki67 cell proliferation index.
Perspectives
This is the landmark paper that in a prospective design demonstrated that FDG-PET better predicts survival in neuroendocrine tumor patients than current classifications, e.g. Ki67 cell proliferation index.
Professor Andreas Kjaer
University of Copenhagen
Read the Original
This page is a summary of: 18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors, Clinical Cancer Research, January 2010, American Association for Cancer Research (AACR),
DOI: 10.1158/1078-0432.ccr-09-1759.
You can read the full text:
Contributors
The following have contributed to this page
